Desonide foam: a review.

Author(s): Parish D, Scheinfeld N

Affiliation(s): Pennsylvania Hospital, University of Pennsylvania, Philadelphia, PA, USA.

Publication date & source: 2008-01, Drugs Today (Barc)., 44(1):55-62.

Publication type: Review

Desonide foam is a newly approved topical corticosteroid preparation of 0.05% desonide. It has been shown effective compared with vehicle placebo in the treatment of mild-to-moderate atopic dermatitis in both pediatric and adult populations. Given the favorable safety profile of all other desonide preparations and their utility as a low potency corticosteroid, desonide foam promises to be a useful addition to the armamentarium, when other desonide vehicles might be less acceptable. (c) 2008 Prous Science, S.A.U. or its licensors.